Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis.
Puyuan XingFan ZhangGuoqiang WangYu XuChengcheng LiShouzheng WangYiying GuoShangli CaiYan WangJun-Ling LiPublished in: Journal for immunotherapy of cancer (2019)
This meta-analysis summarizes the incidence rates of irAEs in patients with advanced solid tumours treated with NIVO or NIVO+IPI, and uncovers their correlations with ORR across multiple neoplasms. These findings highlight the potential of irAE to reflect response to NIVO or NIVO+IPI.